Investigating paediatric hypoglycaemia: Dynamic studies at a tertiary paediatric hospital

Lara E Graves1, Kelly Stewart1, Geoffrey R Ambler1,2

  • 1Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.

Insights

Fasting studies are safe and effective for diagnosing childhood hypoglycaemia and guiding management. These tests help determine causes and safe fasting intervals for affected children.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Clinical Audit

Background:

  • Childhood hypoglycaemia necessitates specific investigations for accurate diagnosis.
  • Diagnostic samples during hypoglycaemic events are often unavailable, requiring alternative testing methods.
  • Fasting studies and glucose challenges are crucial for identifying aetiologies and managing glucose dysregulation.

Purpose of the Study:

  • To review the utility and diagnostic yield of fasting studies, prolonged oral glucose challenges, and starch loads in paediatric patients.
  • To assess the effectiveness of these tests in diagnosing the cause of hypoglycaemia and guiding management.
  • To evaluate the safety and outcomes of these diagnostic procedures.

Main Methods:

  • A retrospective audit of clinical records was conducted.
  • Data were collected from a Tertiary Paediatric Endocrine/Metabolic Testing Unit in Sydney, Australia (2013-2018).
  • The audit reviewed the purpose, procedures, and outcomes of 170 tests in 138 children.

Main Results:

  • 170 tests were performed, including 122 fasting studies, 20 oral glucose tolerance tests (OGTTs), and 48 starch load tests.
  • Diagnostic studies were performed in 66% of cases, leading to a pathological diagnosis in 31% (most common: accelerated starvation).
  • Management studies (34%) informed safe fasting durations, medication/diet adjustments, and pathology resolution.

Conclusions:

  • Fasting studies are a safe and effective diagnostic tool for childhood hypoglycaemia.
  • These studies aid in confirming or excluding pathological causes of hypoglycaemia.
  • Fasting studies are valuable for guiding the management of diagnosed paediatric hypoglycaemia cases.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
551
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
131
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
106
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
412